ATP13A2
protein-codingATPase cation transporting 13A2, the group of ATPase orphan transporters
Gene summary
This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
- PARK9
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~26.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011706
Submitter: ClinGen
*ATP13A2* was first reported in relation to autosomal recessive Kufor-Rakeb syndrome in 2006 (Ramirez et al., PMID: 16964263). It was later reported in relation to other autosomal recessive neurodegenerative disorders including hereditary spastic paraplegia, cerebellar ataxia, amyotrophic lateral sclerosis (ALS), and neuronal ceroid lipofuscinosis. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there is insufficient evidence of a difference in molecular mechanisms or inheritance pattern to explain the wide phenotypic spectrum observed from *ATP13A2* variation; therefore, the Intellectual Disability and Autism Gene Curation Expert Panel decided to lump all these entities together and curate them under the umbrella term Kufor-Rakeb syndrome. Evidence supporting the relationship between *ATP13A2* and a complex movement disorder includes case-level data, segregation data, and experimental data. For the purposes of this curation, nine variants (missense, splicing, nonsense, and frameshift) reported in seven probands in six publications are included in this curation: (PMIDs: 16964263, 21696388, 27165006, 31944623, 33033738, 30992063). In addition, variants in this gene segregated with disease in at least three families (PMIDs: 11584046, 16964263, 21696388). More genetic evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be bi-allelic loss of function (LoF). This gene-disease association is also supported by animal models and in vitro functional assays (PMIDs: 22647602, 22442086, 23393156, 25855184, 30992063). In summary, *ATP13A2* is definitively associated with autosomal recessive Kufor-Rakeb syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on the meeting date April 14, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0014975
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014975
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0011706
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011706
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014975
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0017809
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011706
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0011706
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014975
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: Neurologic
Rationale: In Kufor-Rakeb syndrome, response to levodopa has been documented
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ATP13A2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022089.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 20 | 314 | 4 | 338 | ||
| missense | 3 | 6 | 439 | 65 | 513 | |
| nonsense | 15 | 12 | 1 | 28 | ||
| start loss | 1 | 1 | ||||
| frameshift | 29 | 14 | 3 | 46 | ||
| splice donor/acceptor (+/-2bp) | 1 | 21 | 3 | 25 | ||
| Total | 48 | 53 | 467 | 379 | 4 | 951 |
Highest pathogenic variant AF is 0.00007993377
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_071372.1 | 29 | MANE Select | |
| Ensembl | ENSP00000327214.8 | 29 | MANE Select | |
| RefSeq | NP_001135445.1 | 29 | Standard | |
| RefSeq | NP_001135446.1 | 27 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| atp13a2 | Danio rerio | Structure: whole organism Quality: increased curvature abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ion channel transport
- Transport of small molecules
- Ion transport by P-type ATPases
Biological Process
- cellular calcium ion homeostasis
- cellular iron ion homeostasis
- cellular zinc ion homeostasis
- regulation of mitochondrion organization
- regulation of macroautophagy
Molecular Function
- protein binding
- ATP binding
- zinc ion binding
- ATPase activity
- cation-transporting ATPase activity
Cellular Component
- lysosome
- lysosomal membrane
- late endosome
- multivesicular body
- autophagosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000326735
- Coding exons
- 29
- Length
- 25971
- Individuals with no LoFs
- 125647
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 101
- Defined
- 125748
- p
- 0.000402
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.40 | 624 | 731 | 0.854 | 0.0000508 | 7465 |
| Missense (PolyPhen) | 186 | 241.28 | 0.7709 | 2622 | ||
| Synonymous | -0.537 | 342 | 330 | 1.04 | 0.0000243 | 2564 |
| Loss of Function | 4.12 | 24 | 57.8 | 0.415 | 0.00000289 | 620 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00050 | 0.00049 | rare |
| Latino/Admixed American | 0.00041 | 0.00040 | rare |
| Ashkenazi Jewish | 0.0025 | 0.0025 | notable |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.00010 | 0.000092 | rare |
| European (Non-Finnish) | 0.00032 | 0.00032 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00082 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: ATPase that plays a role in intracellular cation homeostasis and the maintenance of neuronal integrity (PubMed:22186024). Required for a proper lysosomal and mitochondrial maintenance (PubMed:22296644, PubMed:28137957). {ECO:0000269|PubMed:22186024, ECO:0000269|PubMed:22296644, ECO:0000269|PubMed:28137957}.;
- Disease
- DISEASE: Kufor-Rakeb syndrome (KRS) [MIM:606693]: A rare form of autosomal recessive juvenile or early-onset, levodopa-responsive parkinsonism. In addition to typical parkinsonian signs, clinical manifestations of Kufor-Rakeb syndrome include behavioral problems, facial tremor, pyramidal tract dysfunction, supranuclear gaze palsy, and dementia. {ECO:0000269|PubMed:16964263, ECO:0000269|PubMed:17485642, ECO:0000269|PubMed:18413573, ECO:0000269|PubMed:20683840, ECO:0000269|PubMed:20853184, ECO:0000269|PubMed:21542062, ECO:0000269|PubMed:22296644, ECO:0000269|PubMed:22388936, ECO:0000269|PubMed:22768177, ECO:0000269|PubMed:28137957}. Note=The disease is caused by mutations affecting the gene represented in this entry. KRS has also been referred to as neuronal ceroid lipofuscinosis 12 (CLN12), due to neuronal and glial lipofuscin deposits detected in the cortex, basal nuclei and cerebellum of some patients. {ECO:0000269|PubMed:22388936}.; DISEASE: Spastic paraplegia 78, autosomal recessive (SPG78) [MIM:617225]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. {ECO:0000269|PubMed:27217339, ECO:0000269|PubMed:28137957}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.161
Intolerance Scores
- LoFtool
- 0.0289
- RVIS EVS
- -1.16
- RVIS percentile EVS
- 6.1
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.227
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |